How MetaResearch makes money

MetaResearch is paid for by display advertising on the site and by offers from partners in its email briefings. Both are labelled where they appear, and every partner message names the partner. Advertisers and partners have no say in which studies are covered, what a briefing concludes, or how a finding is described, and no advertiser sees a briefing before it is published. Where an offer relates to a subject MetaResearch also reports on, the reporting is written from the primary sources exactly as it would have been with no offer attached.

What the money does not buy

• Every factual claim links to a paper, a trial registry record or an official label.
• Figures are reported as the investigators reported them, including the ones that weaken the headline.
• The strength of the evidence is named beside the finding: randomised trial, records study, review, animal work, or unpublished announcement.
• Findings that have not been through peer review are labelled as such wherever they appear.
• When two credible studies disagree, both are reported and neither is presented as settled.
• MetaResearch never gives medical advice, never recommends taking anything, and never describes how a substance would be used in a person.
• Advertising and partner offers are labelled, and they play no part in choosing or writing a briefing.

Contact

Corrections, source queries and press notes reach the editor at editor@metaresearch.group. Corrections are made on the page itself, with a dated note.

editor@metaresearch.group

Editorial standards · Privacy